Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Neuropharmacol. 2005 Sep-Oct;28(5):215-9.

Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.

Author information

  • 1Department of Clinical Neurosciences, Brown Medical School, Providence, Rhode Island, USA. Kelvin_Chou@brown.edu

Abstract

OBJECTIVES:

To describe further the phenomenology of drug-induced psychosis (DIP) in patients with Parkinson disease (PD) and assess which items on two common psychosis rating instruments-the Brief Psychiatric Rating Scale (BPRS) and the Neuropsychiatric Inventory (NPI)-are the best measure of DIP by comparing them with the Clinical Global Impression Scale (CGIS).

METHODS:

Baseline data from two placebo-controlled, double-blind studies of olanzapine in PD patients with DIP were collected and analyzed.

RESULTS:

A total of 157 of 160 patients had hallucinations, with visual hallucinations being the most common (97% of subjects), followed by auditory (48%), tactile (23%), and olfactory (16%). Seventy-six percent of subjects experienced delusions, and all types of delusions occurred with relatively equal frequency. The CGIS correlated with suspiciousness, hallucinatory behavior, unusual thought content, and hostility on the BPRS; and delusions, hallucinations, agitation, aberrant motor behavior, and sleep on the NPI.

CONCLUSION:

Nonvisual hallucinations and delusions may occur more frequently in DIP than previously thought. These symptoms, plus agitation and hostility, may ultimately be the best measure of DIP in patients with PD.

Comment in

PMID:
16239760
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk